Recital 13, Regulation (EU) 2023/949

In forcesince 12 May 2023

The applicant declared that it held proprietary and exclusive rights of reference to the scientific studies and data submitted in support of the application, namely, the in vitro study on the digestibility of iron milk caseinate under simulated gastric conditions; the certificates of the compositional analyses of the production batches of iron milk caseinate; the in vitro study on the impact of ascorbic acid on the iron bioavailability of iron milk caseinate; and, the randomised human study with a cross over design on the bioavailability of iron from whole milk containing iron milk caseinate as compared to ferrous sulfate, and that third parties cannot lawfully access, use or refer to those data.